Company History
Orteq Ltd is headquartered in London, UK and was established in 2005 to develop and commercialize products using our proprietary polymer technology.
Orteq has developed and obtained CE mark for its first product Actifit®, a biodegradable, polymer scaffold, especially designed to promote new tissue growth in damaged areas of the meniscus that have become torn and then removed.
Actifit® received its CE Mark in mid 2008, and is now approved for use throughout the European Union. During 2009, Orteq will actively seek approval for Actifit® in other regions of the world.
Our new biomaterial has been developed over the past two decades, refined and focussed for clinical use. It possesses unique properties that make it an effective, biodegradable scaffold. Actifit® helps facilitate the human body's natural healing process by providing the material into which blood can flow and reach the injured area and with it the oxygen, nutrients and fibroblasts needed for new cellular in-growth.
Orteq targeted knee injuries first with Actifit® because there is no option to regenerate a patient's meniscus once the damaged section of the meniscus has been removed via a partial meniscectomy. Every year there are more than 1,500,000 meniscectomies and 630,000 total knee replacements performed in the US and Europe. Therefore, Actifit® has the potential to satisfy a major unmet clinical need.
We believe that this biodegradable scaffold can be adapted for use throughout the body and will help promote new tissue in-growth in a variety of areas of the body.
Orteq's manufacturing/research and development is housed in a state-of-the-art, 5,000 sq ft facility in Groningen, The Netherlands.